Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Pathophysiology ; 26(3-4): 343-347, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31542308

RESUMO

Vanillylmandelic acid, a catecholamine end-metabolite, has been shown to have several biological properties in previous studies, despite considered biologically inactive. We examined the potential effects of vanillylmandelic acid on the ischemic heart following myocardial infarction and reperfusion on a rat model. Thirty-four female Wistar rats were randomized into two groups, control and experimental. They were anesthetized and subjected to myocardial infarction through left anterior descending artery ligation. A previously studied dose of vanillylmandelic acid (10 mg/kg) was administered and the following parameters were studied during ischemia and reperfusion: a) mortality b) severity of ventricular tachyarrhythmias c) premature ventricular contractions and d) heart rate. Administration of vanillymandelic acid significantly reduced the severity of ventricular tachyarrhythmias and mortality rate during reperfusion, while it did not affect any other of the parameters studied. In conclusion, reperfusion injury was blunted through vanillylmandelic acid administration, which seems to be mediated by parasympathetic activation.

2.
Ren Fail ; 38(5): 738-43, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26983797

RESUMO

Chronic kidney disease is a condition that promotes oxidative stress. There are conflicting evidence about the role of hemodialysis on oxidative stress, that are mostly related with the various types of membrane materials used, the quality and type of dialysate, the method used, etc. The phase angle (PhA), which is determined with bioelectrical impedance analysis (BIA), measures the functionality of cell membranes. In this study, the correlation of the PhA with parameters of oxidative stress is attempted for the first time. We evaluated parameters of oxidative status as total antioxidant capacity (TAC) in erythrocytes (RBCs) and plasma of patients with ESRD undergoing hemodialysis with low flux synthetic polysulfone membranes. Measurements were recorded from 30 patients (16 men and 14 women) aged 64 ± 14 years before, during, and after dialysis, and in 15 healthy volunteers aged 56 ± 12 years The PhA was obtained by BIA. The plasma TAC increased significantly (41%, p < 0.05). Intracellular TAC noted a non-significant increase. Total antioxidant capacity of the patients before and after hemodialysis was significantly lower from the healthy volunteers (p < 0.05) showing that ESRD patients are at the state of increased oxidative stress. The PhA increased in significantly positive correlation with plasma TAC at the end of hemodialysis. The process of hemodialysis with biocompatible synthetic membranes and bicarbonate dialysate improved plasma TAC. The positive correlation of PhA with extracellular TAC could evolve to a method of oxidative stress estimation by BIA but further research is needed.


Assuntos
Antioxidantes/metabolismo , Soluções para Diálise/farmacologia , Impedância Elétrica , Falência Renal Crônica , Polímeros/farmacologia , Diálise Renal , Sulfonas/farmacologia , Idoso , Materiais Biocompatíveis/farmacologia , Feminino , Humanos , Falência Renal Crônica/metabolismo , Falência Renal Crônica/fisiopatologia , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Avaliação de Processos e Resultados em Cuidados de Saúde , Estresse Oxidativo , Diálise Renal/efeitos adversos , Diálise Renal/instrumentação , Diálise Renal/métodos , Estatística como Assunto
3.
Electromagn Biol Med ; 31(4): 275-84, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22690703

RESUMO

Exposure to various types of electromagnetic fields (EMFs) affects pain specificity (nociception) and pain inhibition (analgesia). Previous study of ours has shown that exposure to the resonant spectra derived from biologically active substances' NMR may induce to live targets the same effects as the substances themselves. The purpose of this study is to investigate the potential analgesic effect of the resonant EMFs derived from the NMR spectrum of morphine. Twenty five Wistar rats were divided into five groups: control group; intraperitoneal administration of morphine 10 mg/kg body wt; exposure of rats to resonant EMFs of morphine; exposure of rats to randomly selected non resonant EMFs; and intraperitoneal administration of naloxone and simultaneous exposure of rats to the resonant EMFs of morphine. Tail Flick and Hot Plate tests were performed for estimation of the latency time. Results showed that rats exposed to NMR spectrum of morphine induced a significant increase in latency time at time points (p < 0.05), while exposure to the non resonant random EMFs exerted no effects. Additionally, naloxone administration inhibited the analgesic effects of the NMR spectrum of morphine. Our results indicate that exposure of rats to the resonant EMFs derived from the NMR spectrum of morphine may exert on animals similar analgesic effects to morphine itself.


Assuntos
Analgesia/métodos , Magnetoterapia/métodos , Morfina/química , Animais , Comportamento Animal , Espectroscopia de Ressonância Magnética , Medição da Dor , Ratos , Ratos Wistar
4.
Electromagn Biol Med ; 30(1): 46-56, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21554101

RESUMO

The main objective of our study is to investigate whether an enhancement of the immune system in end-stage cancer patients is achieved by exposure to coherent electromagnetic fields. For this reason, 15 end-stage cancer patients were exposed at low intensity, coherent electromagnetic fields at radiofrequencies ranging from 600 kHz-729 Hz, for 8 h/day, 6 days/week for 4 weeks. NKs number and cytotoxicity of NK T-lymphocytes versus K562 cancer cell line were estimated by flow cytometry, before and after exposure. Data showed that the exposure of the end-stage cancer patients to the coherent electromagnetic fields resulted in a significant increase of the number and the cytotoxicity of the NK T-lymphocytes against cancer cells, in all patients. Exposure to coherent EMFs at radiofrequencies increases the number and cytotoxicity of NK T-lymphocytes, which may contribute to the improvement of cancer patients' status.


Assuntos
Campos Eletromagnéticos , Células Matadoras Naturais/efeitos da radiação , Neoplasias/radioterapia , Terapia de Salvação/métodos , Adulto , Idoso , Linhagem Celular Tumoral , Feminino , Citometria de Fluxo , Humanos , Células K562 , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Masculino , Pessoa de Meia-Idade , Neoplasias/classificação , Neoplasias/imunologia , Neoplasias/metabolismo , Linfócitos T Citotóxicos/imunologia , Linfócitos T Citotóxicos/metabolismo , Linfócitos T Citotóxicos/efeitos da radiação , Fatores de Tempo
5.
Gynecol Endocrinol ; 26(4): 250-5, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20222839

RESUMO

OBJECTIVE: To investigate whether there is a fluctuation of the copper and zinc plasma levels during the menstrual cycle and if this correlates to the physiological fluctuations of estradiol and progesterone plasma concentrations in eumenorrhoic women. METHODS: We studied 14 eumenorrhoic women. Copper (Cu), zinc (Zn), estradiol (E2) and progesterone (Prg) plasma concentrations, during time of menstruation (time 1), midfollicular phase (time 2), time of ovulation (time 3) and midluteal phase (time 4) were determined. RESULTS: We observed significant changes in both copper plasma concentrations and zinc plasma concentrations during the four times studied (p < 0.05). The changes of Cu during the various phases correlated negatively with the changes in E2 (r > 0.5, p < 0.05), whereas the changes of Zn correlated positively with those of E2 (r > 0.8, p < 0.05). We were unable to demonstrate any statistically significant correlation between Cu and Prg or Zn and Prg. CONCLUSIONS: This study indicates that there is a cyclic fluctuation of Cu and Zn concentrations in plasma during the menstrual cycle, in healthy eumenorrhoic women. This cyclic fluctuation might be due to the cyclic fluctuation of plasma levels of E2.


Assuntos
Cobre/sangue , Ciclo Menstrual/sangue , Zinco/sangue , Adulto , Estradiol/sangue , Feminino , Humanos , Progesterona/sangue , Adulto Jovem
6.
J Inorg Biochem ; 208: 111074, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32497827

RESUMO

Novel vitamin E chelate derivatives and their VIV/V complexes have been synthesized and characterized, and their anticancer properties have been evaluated. The new complexes have been designed to exhibit enhanced cytotoxicity by combining high lipophilicity with the properties of vanadium to induce the formation of reactive oxygen species (ROS). In particular, the ß-tocopherol derivatives with iminodiethanol (ß-tocDEA) and dipicolylamine (ß-tocDPA) as well their VV and VIV complexes, [VVO(ß-tocDEA] and [VIVO(ß-tocDPA] have been synthesized and characterized by Nuclear Magnetic Resonance (NMR), Ultra Violet-Visible (UV-Vis) and Electron Paramagnetic Resonance (EPR) spectroscopies. Although the ß-tocopherol compounds exhibit antioxidant activity their complexes induce formation of radicals. In addition, two vanadium amphiphilic complexes of 2,2'-((2-hydroxyoctadecyl)azanediyl)bis(ethan-1-ol) (C18DEA) and 1-(bis(pyridin-2-ylmethyl)amino)octadecan-2-ol (C18DPA) known to activate O2 and produce ROS were synthesized and characterized (C. Drouza, A. Dieronitou, I. Hadjiadamou, M. Stylianou, J. Agric. Food. Chem., vol. 65, 2017, pp. 4942-4951). The four amphiphilic vanadium complexes exhibit enhanced hydrolytic stability. All compounds found to be cytotoxic for cancer cells exhibiting activity similar or higher to cis-platin.


Assuntos
Complexos de Coordenação , Citotoxinas , Lipídeos , Neoplasias , Vanádio , Vitamina E , Complexos de Coordenação/síntese química , Complexos de Coordenação/química , Complexos de Coordenação/farmacocinética , Complexos de Coordenação/farmacologia , Citotoxinas/síntese química , Citotoxinas/química , Citotoxinas/farmacocinética , Citotoxinas/farmacologia , Células HEK293 , Células HeLa , Humanos , Lipídeos/síntese química , Lipídeos/química , Lipídeos/farmacocinética , Lipídeos/farmacologia , Neoplasias/tratamento farmacológico , Neoplasias/metabolismo , Neoplasias/patologia , Vanádio/química , Vanádio/farmacocinética , Vanádio/farmacologia , Vitamina E/síntese química , Vitamina E/química , Vitamina E/farmacocinética , Vitamina E/farmacologia
7.
Integr Cancer Ther ; 18: 1534735419872811, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31441361

RESUMO

Background. Cisplatin (cis-diamminedichloroplatinum) is a widely used chemotherapeutic agent for the treatment of various cancers. Although it represents an effective regimen, its application is accompanied by side effects to normal tissues, especially to the kidneys. Cisplatin generates free radicals and impairs the function of antioxidant enzymes. Modulation of cisplatin-induced oxidative stress by specific antioxidant molecules represents an attractive approach to minimize side effects. Methods. We studied the ability of curcumin to sensitize leiomyosarcoma (LMS) cells to cisplatin. Assays for cell proliferation, mitochondrial function, induction of apoptosis, and cell cycle arrest were performed using various concentrations of cisplatin and a concentration of curcumin that caused a nonsignificant reduction in cell viability. Moreover, the effect of curcumin was examined against cisplatin-induced experimental nephrotoxicity. Renal injury was assessed by measuring serum creatinine, blood urea nitrogen (BUN), and the kidney's relative weight. Oxidative stress was measured by means of enzymatic activities of superoxide dismutase and glutathione peroxidase in the rats' blood and malondialdehyde levels in rats' urine. Results. In our study, we found that curcumin sensitizes LMS cells to cisplatin by enhancing apoptosis and impairing mitochondrial function. In an in vivo model of cisplatin-induced experimental nephrotoxicity, intraperitoneal administration of curcumin failed to preserve blood's antioxidant enzyme activity and decrease lipid peroxidation. Nevertheless, curcumin was able to protect nephrons' histology from cisplatin's toxic effect. Conclusion. Our results showed that curcumin can act as chemosensitizer, but its role as an adjunctive cisplatin-induced oxidative stress inhibitor requires further dose-finding studies to maximize the effectiveness of chemotherapy.


Assuntos
Antioxidantes/metabolismo , Cisplatino/farmacologia , Curcumina/farmacologia , Nefropatias/tratamento farmacológico , Leiomiossarcoma/tratamento farmacológico , Animais , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Nitrogênio da Ureia Sanguínea , Linhagem Celular , Creatinina/metabolismo , Feminino , Glutationa/metabolismo , Humanos , Rim/efeitos dos fármacos , Rim/metabolismo , Nefropatias/induzido quimicamente , Nefropatias/metabolismo , Leiomiossarcoma/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo
8.
Med Hypotheses ; 133: 109393, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31563097

RESUMO

The aim of this article is to investigate the potential cytotoxic and antitumor effects of the resonant electromagnetic fields (rEMFs) derived from the 1H NMR spectrum of the Ph3Sn(Mercaptonicotinic)SnPh3 complex (SnMNA). The ability of the complex's rEMFs to induce leiomyosarcoma (LMS) cell death and to recess tumor (leiomyosarcoma) development in Wistar rats was evaluated. The effects of the simultaneous administration of the SnMNA complex at extremely low concentrations and exposure to its rEMFs was also investigated. The emission of the 1H NMR spectrum of the complex alone or in a combination with low ineffective doses of the complex decreased LMS cell viability mainly through apoptosis. Moreover, the results from the in vivo experiments showed a significant prolongation of life expectancy in tumor-bearing rats exposed to the rEMFs alongside a deceleration in tumor growth rate. We speculate that the rEMFs of a biologically active substance could exert similar biological effects as the substance itself, mainly when is combined with extremely low ineffective concentrations of the substance.


Assuntos
Antineoplásicos/uso terapêutico , Leiomiossarcoma/radioterapia , Compostos Orgânicos de Estanho/uso terapêutico , Espectroscopia de Prótons por Ressonância Magnética , Terapia por Radiofrequência/métodos , Animais , Antineoplásicos/química , Antineoplásicos/toxicidade , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/efeitos da radiação , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Campos Eletromagnéticos , Feminino , Humanos , Compostos Orgânicos de Estanho/química , Compostos Orgânicos de Estanho/toxicidade , Distribuição Aleatória , Ratos , Ratos Wistar , Ensaios Antitumorais Modelo de Xenoenxerto
9.
J Med Food ; 21(12): 1197-1203, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30311825

RESUMO

Type 2 diabetes mellitus (T2DM) is evolving to an epidemic of the modern world. T2DM is associated with a number of pathological complications, including cardiovascular disease that is mostly promoted by the increased oxidative stress in type 2 diabetic patients. We performed a randomized double-blind placebo-controlled trial to investigate the effectiveness of an individualized oral supplementation with α-lipoic acid (ALA), carnosine, and thiamine. For that purpose, 82 obese type 2 diabetic patients were randomly assigned to 2 groups, and were either supplemented daily with 7 mg ALA/kg body weight, 6 mg carnosine/kg body weight, and 1 mg thiamine/kg body weight or placebo for 8 weeks. An array of biochemical tests including the estimation of oxidative stress and platelet aggregation were performed at baseline and at follow-up. Moreover, the antiplatelet activity of each of the supplement's components was determined ex vivo at human and washed rabbit platelets. Glucose and HbA1c levels were significantly reduced after supplementation (135.7 ± 19.5 mg/dL vs. 126.5 ± 16.8 mg/dL and 8.3% ± 0.3% vs. 6.03% ± 0.58%, respectively, P < .05); however, insulin was significantly increased (3.6 ± 0.7 µIU/mL vs. 6.8 ± 0.2 µIU/mL, P < .05). The patients treated with the supplement recorded higher follow-up values for HOMA-IR and HOMA-ß, and a significant drop in serum hydroperoxide level. Only ALA inhibited platelets aggregation ex vivo through ADP, platelet activating factor, arachidonic acid, epinephrine, collagen, and thrombin pathways. Daily supplementation with an individualized ALA, carnosine, and thiamine supplement effectively reduced glucose concentration in type 2 diabetic patients, probably by increasing insulin production from the pancreas. In addition to that, the reduction of oxidative stress and inhibition of platelet aggregation could potentially provide greater cardiovascular protection. Further studies are needed to fine-tune the supplementation dose-response effects in T2DM patients.


Assuntos
Diabetes Mellitus Tipo 2/prevenção & controle , Suplementos Nutricionais , Obesidade Mórbida , Administração Oral , Glicemia/metabolismo , Carnosina/administração & dosagem , Carnosina/uso terapêutico , Diabetes Mellitus Tipo 2/sangue , Método Duplo-Cego , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Tiamina/administração & dosagem , Tiamina/uso terapêutico , Ácido Tióctico/administração & dosagem , Ácido Tióctico/uso terapêutico , Resultado do Tratamento
10.
Nat Prod Res ; 32(11): 1337-1342, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28641455

RESUMO

The aim of this study was to investigate the cytotoxic effect cisplatin in combination with epigallocatechin-3-gallate (EGCG) on leiomyosarcoma cells (LMS cells) in order to identify a less toxic but equally effective alternative. Assays for cell proliferation, colony formation efficiency, induction of apoptosis and cell cycle arrest were performed using the IC50 of cisplatin (8.6 µΜ) as a reference value and a concentration of EGCG (30 µΜ) that caused a non-significant reduction in cell proliferation. Pre-treatment of cells with EGCG for 24 h before the addition of cisplatin increased cytotoxicity up to 8.5% (p < 0.05) and the number of apoptotic cells by 40%. Epigallocatechin-3-gallate failed to alter S-phase cell cycle arrest induced by cisplatin and to modulate cisplatin effects on mitochondrial function. These results indicate that pre-treatment with EGCG could be used as an adjunctive therapy to maximise effectiveness of chemotherapy.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Leiomiossarcoma/tratamento farmacológico , Animais , Apoptose/efeitos dos fármacos , Catequina/administração & dosagem , Catequina/análogos & derivados , Ciclo Celular/efeitos dos fármacos , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cisplatino/administração & dosagem , Cisplatino/farmacologia , Concentração Inibidora 50 , Leiomiossarcoma/patologia , Mitocôndrias/efeitos dos fármacos , Ratos Wistar
11.
Hell J Nucl Med ; 10(2): 95-101, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17684584

RESUMO

In the present study, the effects of a resonant low intensity static electromagnetic field (EMF), causing no thermal effects, on Wistar rats have been investigated. Sarcoma cell lines were isolated from leiomyosarcoma tumors induced in Wistar rats by the subcutaneous (s.c) injection of 3,4-benzopyrene. Furthermore, smooth muscle cells (SMC) were isolated from the aorta of Wistar rats and cultivated. Either leiomyosarcoma cells (LSC) or SMC were used to record a number of characteristic resonant radiofrequencies, in order to determine the specific electromagnetic fingerprint spectrum for each cell line. These spectra were used to compose an appropriate algorithm, which transforms the recorded radiofrequencies to emitted ones. The isolated LSC were cultured and then exposed to a resonant low intensity radiofrequency EMF (RF-EMF), at frequencies between 10 kHz to 120 kHz of the radiowave spectrum. The exposure lasted 45 consecutive minutes daily, for two consecutive days. Three months old female Wistar rats were inoculated with exposed and non-exposed to EMF LSC (4 x 10(6) LCS for animal). Inoculated with non-exposed to EMF cells animals were then randomly separated into three Groups. The first Group was sham exposed to the resonant EMF (control Group-CG), the second Group after the inoculation of LSC and appearance of a palpable tumor mass, was exposed to a non-resonant EMF radiation pattern, for 5 h per day till death of all animals (experimental control Group-ECG). The third Group of animals after inoculation of LSC and the appearance of a palpable tumor mass, was exposed to the resonant EMF radiation for 5 h per day, for a maximum of 60 days (experimental Group-I, EG-I). A fourth Group of animals was inoculated with LSC exposed to EMF irradiation and were not further exposed to irradiation (experimental Group-II, EG-II). Tumor induction was 100% in all Groups studied and all tumors were histologically identified as leiomyosarcomas. In the case of the EG-I, a number of tumors were completely regretted (final tumor induction: 66%). Both Groups of animals inoculated with exposed or non-exposed to the EMF LSC, (EG-I and EG-II, respectively) demonstrated a significant prolongation of the survival time and a lower tumor growth rate, in comparison to the control Group (CG) and the experimental control Group (ECG). However, the survival time of EG-I animals was found to be significantly longer and tumor growth rate significantly lower compared to EG-II animals. In conclusion, our results indicate a specific anticancer effect of resonant EMF irradiation. These results may possibly be attributed to (a) the duration of exposure of LSC and (b) the exposure of the entire animal to this irradiation.


Assuntos
Antineoplásicos/uso terapêutico , Campos Eletromagnéticos , Leiomiossarcoma/radioterapia , Animais , Aorta/metabolismo , Modelos Animais de Doenças , Feminino , Humanos , Miócitos de Músculo Liso/metabolismo , Neoplasias/metabolismo , Ondas de Rádio , Ratos , Ratos Wistar , Fatores de Tempo , Resultado do Tratamento
12.
Hell J Nucl Med ; 9(3): 167-72, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17160157

RESUMO

In this study we investigated the effects of low intensity static radiofrequency electromagnetic field (EMF) causing no thermal effects, on leiomyosarcoma cells (LSC), isolated from tumors of fifteen Wistar rats induced via a 3,4-benzopyrene injection. Electromagnetic resonance frequencies measurements and exposure of cells to static EMF were performed by a device called multi channel dynamic exciter 100 V1 (MCDE). The LSC were exposed to electromagnetic resonance radiofrequencies (ERF) between 10 kHz to 120 kHz, for 45 min. During a 24h period, after the exposure of the LSC to ERF, there was no inhibition of cells proliferation. In contrast, at the end of a 48 h incubation period, LSC proliferation dramatically decreased by more than 98% (P<0.001). At that time, the survived LSC were only 2% of the total cell population exposed to ERF, and under the same culture conditions showed significant decrease of proliferation. These cells were exposed once again to ERF for 45 min (totally 4 sessions of exposure, of 45 min duration each) and tested using a flow cytometer. Experiments as above were repeated five times. It was found that 45% of these double exposed to ERF, LSC (EMF cells) were apoptotic and only a small percentage 2%, underwent mitosis. In order to determinate their metastatic potential, these EMF cells were also counted and tested by an aggregometer for their ability to aggregate platelets and found to maintain this ability., since they showed no difference in platelet aggregation ability compared to the LSC not exposed to ERF (control cells). In conclusion, exposure of LSC to specific ERF, decreases their proliferation rate and induces cell apoptosis. Also, the LSC that survived after exposed to ERF, had a lower proliferation rate compared to the LSC controls (P<0.05) but did not loose their potential for metastases (platelet aggregation ability). The non-malignant SMC were not affected by the EMF exposure (P<0.4). The specific ERF generated from the MCDE electronic device, used in this study, is safe for humans and animals, according to the international safety standards.


Assuntos
Proliferação de Células/efeitos da radiação , Sobrevivência Celular/efeitos da radiação , Campos Eletromagnéticos , Leiomiossarcoma/patologia , Miócitos de Músculo Liso/citologia , Miócitos de Músculo Liso/efeitos da radiação , Ondas de Rádio , Animais , Linhagem Celular , Relação Dose-Resposta à Radiação , Feminino , Masculino , Doses de Radiação , Ratos , Ratos Wistar
13.
Data Brief ; 8: 692-6, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27508219

RESUMO

Due to its rarity and unique biological traits, as well as its growing financial value, milk of dairy Greek small ruminants is continuously attracting interest from both the scientific community and industry. For the construction of the present dataset, cutting-edge proteomics methodologies were employed, in order to investigate and characterize, for the first time, the milk whey proteome from the two indigenous Greek goat breeds, Capra prisca and Skopelos. In total 822 protein groups were identified in milk whey of the two breeds, The present data are further discussed in the research article "Milk of Greek sheep and goat breeds; characterization by means of proteomics" [1].

14.
Data Brief ; 8: 877-80, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27508236

RESUMO

The importance and unique biological traits, as well as the growing financial value, of milk from small Greek ruminants is continuously attracting interest from both the scientific community and industry. In this regard the construction of a reference dataset of the milk of the Greek sheep breeds is of great interest. In order to obtain such a dataset we employed cutting-edge proteomics methodologies to investigate and characterize, the proteome of milk from the three indigenous Greek sheep breeds Mpoutsko, Karagouniko and Chios. In total, more than 1300 protein groups were identified in milk whey from these breeds, reporting for the first time the most detailed proteome dataset of this precious biological material. The present results are further discussed in the research paper "Milk of Greek sheep and goat breeds; characterization by means of proteomics" (Anagnostopoulos et al. 2016) [1].

15.
J Proteomics ; 147: 76-84, 2016 09 16.
Artigo em Inglês | MEDLINE | ID: mdl-27102495

RESUMO

UNLABELLED: Over the past 30years there has been a growing interest to unravel the dynamic framework of the milk proteome, and now that available technology is mature enough to enable techniques of protein fractionation and identification, this process is on-going. Due to its rarity and unique biological traits, as well as its growing financial value, milk of dairy Greek animals is continuously attracting interest from both the scientific community and industry. In the present study we employed cutting-edge proteomics methodologies to investigate and characterize, in depth, the proteome of whey from all pure-breed Greek sheep and goats. A mean of >500 protein groups were identified in whey from each breed of each animal species, reporting for the first time the proteome dataset of this precious biological material. Given its high nutritional value, the protein properties exposed herein will govern future steps in optimizing characteristics and features of sheep and goat milk products. SIGNIFICANCE: In the present study we employed cutting-edge proteomics methodologies to investigate and characterize, in depth, the proteome of milk from all pure-breed Greek sheep and goats. A mean of >500 protein groups were identified in milk whey from each breed of each animal species, reporting for the first time the proteome dataset of this precious biological material. Given its high nutritional value, the protein properties exposed herein will govern future steps in optimizing characteristics and features of sheep and goat milk products.


Assuntos
Leite/química , Proteoma/análise , Proteômica/métodos , Animais , Cabras , Grécia , Ovinos , Proteínas do Soro do Leite/análise
16.
In Vivo ; 29(1): 55-63, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25600531

RESUMO

AIM: This study was carried-out to investigate the effect of four different silver substances (S1, S2, S3, and S4) on burn wound healing in a rat model. MATERIALS AND METHODS: One hundred and eighty Wistar rats were used. Animals were randomized into six groups to receive no treatment (CG, control group), and local application of the solvent of silver substances (SG, solvent group), as well as of the four silver substances (EG1-EG4 groups for substances S1-S4, respectively). On days 0, 3, 6, 12, 21, and 31 following burn wound infliction, the size and healing progress of each wound were recorded and evaluated by means of clinical evaluation, planimetry and histological examination. RESULTS: According to our findings lower infection rates, as well as significantly accelerated wound healing and faster re-epithelialization were recorded in EG1, EG2, and EG4 compared to the other groups. DISCUSSION: The use of S1, S2, and S4 substances proved to be an effective treatment of burn wounds that ensured better outcomes compared to the control and solvent groups, as well as with the use of S3 substance. Nevertheless, they failed to produce short-term healing of the full-thickness burn. Further research is required to examine the possibility of speeding the treatment of full-thickness burns by these complexes in order to reduce healing time to acceptable limits and prevent the need for surgery.


Assuntos
Queimaduras/tratamento farmacológico , Compostos de Prata/farmacologia , Compostos de Prata/uso terapêutico , Pele/efeitos dos fármacos , Pele/patologia , Cicatrização/efeitos dos fármacos , Animais , Queimaduras/etiologia , Modelos Animais de Doenças , Feminino , Estrutura Molecular , Ratos , Compostos de Prata/química , Fatores de Tempo
17.
In Vivo ; 17(1): 101-3, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12655800

RESUMO

BACKGROUND: Lipid-lowering drugs have been developed to treat hyperlipidemia, but they are expensive, while serious side-effects may occasionally occur. In Albania, a hydroalcoholic extract of the cones of Cupressus sempervirens is used to treat a variety of disorders, including hyperlipidemia. The purpose of our study was to assess the effects of Cupressus sempervirens cone extract (CSE) on the lipid profile of Wistar rats. MATERIALS AND METHODS: The animals were divided into two groups. Group I (30 animals) served as a control group. Serum lipid parameters, muscle and liver enzymes, red and white blood count, platelets, and serum concentrations of uric acid and creatinine were determined at baseline and at weeks 6, 12, 18 and 24 of the study. RESULTS: The oral administration of the extract resulted in a substantial decrease of serum total cholesterol, which was significant even after 6 weeks of treatment. Moreover, these animals exhibited lower total cholesterol levels compared to the controls after the initiation of treatment (p < 0.001) during the study period. The administration of the extract led to a substantial reduction in serum triglycerides (p < 0.05) in Group I, comparing 0 week to 6-24 weeks. However no significant differences in triglyceride levels were observed between CSE animals (Group I) and controls (Group II) during the entire study period. No significant changes in HDL-cholesterol in the other parameters occurred in either group. CONCLUSION: The administration of CSE has an important lipid-lowering effect in Wistar rats.


Assuntos
Cupressus , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/farmacologia , Fitoterapia , Extratos Vegetais/farmacologia , Animais , Colesterol/sangue , Hiperlipidemias/sangue , Masculino , Ratos , Ratos Wistar , Triglicerídeos/sangue
18.
Int Urol Nephrol ; 45(4): 1137-44, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23212145

RESUMO

PURPOSE: Chronic renal failure patients undergoing peritoneal dialysis (PD) are characterized by increased oxidative stress (OS), which is associated with enhanced cardiovascular risk. Moreover, oxidative stress also contributes to peritoneal membrane changes and ultrafiltration failure. The aim of this study was to evaluate OS in PD patients and the effect of treatment with ascorbic acid and α-tocopherol. METHODS: Plasma, erythrocyte, urine, and peritoneal effluent samples from 20 patients on PD were evaluated for glutathione peroxidase and superoxide dismutase activity, total antioxidant capacity (TAC) and malondialdehyde (MDA) levels, as well as protein carbonyl formation, before and after administration of vitamin C, alone or in combination with vitamin E, in comparison with 10 apparently healthy control individuals. RESULTS: All studied markers showed enhanced OS in the PD group, compared to controls. The supplementation of vitamin C and E resulted in improvements of all the OS markers, as indicated by increased erythrocyte antioxidant enzymes activity and TAC levels, as well as decreased MDA concentration and carbonyl compound formation. CONCLUSIONS: The oral supplementation of antioxidant vitamins C and E, in combination, can lead to decreased OS, thus providing a useful and cost-effective therapeutic option in PD patients.


Assuntos
Ácido Ascórbico/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Falência Renal Crônica/terapia , Estresse Oxidativo/efeitos dos fármacos , Diálise Peritoneal Ambulatorial Contínua/efeitos adversos , Vitamina E/uso terapêutico , Idoso , Análise de Variância , Doenças Cardiovasculares/etiologia , Estudos de Casos e Controles , Suplementos Nutricionais , Feminino , Seguimentos , Glutationa Peroxidase/análise , Glutationa Peroxidase/metabolismo , Humanos , Falência Renal Crônica/diagnóstico , Masculino , Malondialdeído/análise , Malondialdeído/metabolismo , Pessoa de Meia-Idade , Diálise Peritoneal Ambulatorial Contínua/métodos , Valores de Referência , Estudos Retrospectivos , Medição de Risco , Superóxido Dismutase/análise , Superóxido Dismutase/metabolismo , Resultado do Tratamento
19.
Eur J Pharmacol ; 703(1-3): 46-52, 2013 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-23399766

RESUMO

The main catecholamine end-metabolites have been considered biologically inactive, but accumulated evidence indicates a variety of pharmacological actions after exogenous administration. We examined the dose-related haemodynamic effects of vanillylmandelic acid in the in vivo rat-model. One hundred and sixteen Wistar rats (250 ± 20 g) were studied under continuous electrocardiographic monitoring; invasive blood pressure was recorded for 60 min through a catheter in the right common carotid artery. Measurements were performed at baseline and after vanillylmandelic acid (1, 10, 100mg/kg) and homovanillic acid (10mg/kg) intra-arterial administration. To examine the underlying mechanisms, the haemodynamic effects were compared with those (a) after trimetazidine administration, which has similar structure due to a tri-methylated phenolic ring; (b) after epinephrine and isoprenaline administration following vanillylmandelic acid pretreatment; (c) after vanillylmandelic acid administration post-bilateral vagotomy. Vanillylmandelic acid, homovanillic acid and (to a lesser extent) trimetazidine decreased heart rate and mean arterial blood pressure. This effect was blunted in vagotomized animals. Comparable effects were noted in heart rate and blood pressure after adrenaline and isoprenaline infusion, with and without vanillylmandelic acid-pretreatment. In conclusion, vanillylmandelic acid administration decreases heart rate dose-dependently, mediated by increased vagal tone, without α- or ß-adrenergic-receptor blocking effects. The pharmacological properties of compounds with a mono- and tri-methylated phenolic ring merit further investigation.


Assuntos
Fármacos Cardiovasculares/farmacologia , Ácido Vanilmandélico/farmacologia , Agonistas alfa-Adrenérgicos/farmacologia , Agonistas Adrenérgicos beta/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Epinefrina/farmacologia , Feminino , Frequência Cardíaca/efeitos dos fármacos , Isoproterenol/farmacologia , Ratos , Ratos Wistar , Vagotomia , Estimulação do Nervo Vago
20.
Eur J Pharm Sci ; 47(2): 490-6, 2012 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-22841513

RESUMO

Since the initial success of cisplatin, metal complexes and organometallic compounds have been gaining growing interest in cancer therapy. It is well known that organotin(IV) compounds display strong biological activity. The triorganotin compound [(C(6)H(5))(3)Sn(cmbzt)] (cmbzt=5-chloro-2-mercaptobenzothiazole) (SnCMB), was tested for its antiproliferative and antitumour activities. Two sets of experimental procedures were followed: (1) In vitro and ex vivo procedures included the study of the cytotoxic activity of the complex against leiomyosarcoma cells (LMS) and on a normal human fibroblast line (MRC5) by the MTT assay (cell proliferation), colony formation efficiency and flow cytometric analysis with Annexin V-FITC. The anticoagulation properties of the complex were also studied. (2) In vivo procedures included acute toxicity studies and finally administration of the complex to tumour bearing Wistar rats. The results showed that the complex exhibited potent cytotoxic activity (LMS IC(50)=155 nM) and induced significant apoptosis against LMS cells. Acute toxicity studies on Wistar rats presented kidney and liver toxicity at a single dose of 40 mg/kg body wt. Furthermore, antitumour activity studies on sarcoma bearing Wistar rats revealed that SnCMB complex, administrated in two different therapeutic schemes (treated with 4 × 2 mg/kg body wt every 5 days and 3 × 2.67 mg/kg body wt every 10 days of SnCMB complex), prolonged mean survival time (by 50% and 70% respectively), but failed to decrease the mean tumour growth rate (MTGR) compared to the control group (p<0.01). In conclusion, the organic complex SnCMB possess potent cytotoxic and antimetastatic effects, and low toxicity introducing it as possible successor of organometallic compounds used nowadays in chemotherapy.


Assuntos
Antineoplásicos/uso terapêutico , Compostos Orgânicos de Estanho/uso terapêutico , Animais , Antineoplásicos/farmacologia , Linhagem Celular , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Feminino , Humanos , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Compostos Orgânicos de Estanho/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Ratos , Ratos Wistar , Carga Tumoral/efeitos dos fármacos , Ensaios Antitumorais Modelo de Xenoenxerto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA